Acral erythema: a clinical review.
Acral erythema is a localized chemotherapy-induced cutaneous response that has been observed in patients with either hematologic malignancies or solid tumors. An illustrative case of acral erythema in a woman with acute myelogenous leukemia is reported. The patient initially presented in blast crisis with concurrent cutaneous lesions of Sweet's syndrome. She subsequently showed acral erythema after being treated with cytosine arabinoside and idarubicin (an analogue of doxorubicin). The pathogenesis and treatment of acral erythema are reviewed.
Cohen
P R
PR
Department of Dermatology, University of Texas Medical School, Houston 77030.
D000970:Antineoplastic Agents / Q000009:adverse effects; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000473:pathology; D004890:Erythema / Q000139:chemically induced / Q000150:complications / Q000175:diagnosis / Q000473:pathology*; D005121:Extremities; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications; D008875:Middle Aged; D016463:Sweet Syndrome / Q000150:complications / Q000175:diagnosis / Q000473:pathology
D000970:Antineoplastic Agents